Materials · Chemicals & Allied Products

IOSP INNOSPEC INC. SEC Filings & Insider Trading Activity 2026

company
CIK 1054905114 filings
Russell 2000

IOSP at a glance

INNOSPEC INC. (IOSP, SEC CIK 1054905) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), INNOSPEC INC. (IOSP) reported revenue of $1.8 billion (down 3.7% from FY2024) and net income of $116.6 million. Diluted EPS was $4.67.
  • As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding INNOSPEC INC. (IOSP) shares worth $1.3 billion in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by PARRETTE LESLIE J on November 10, 2026 of 345 shares at $79.69 per share.
  • In the last 90 days, IOSP insiders reported 1 open-market purchase ($27K) and 0 open-market sales ($0) on Form 4, a net purchase of $27K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$1.8B
−3.7% vs prior year
Insiders · 90 days
1 buy · 0 sells
Net +$27K
13F holders
30 funds
$1.3B · +1 vs prior quarter
Latest 8-K
Nov 3, 2026
Item 2.02 · Item 7.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business: Specialty chemicals for Performance Chemicals, Fuel Specialties, and Oilfield Services segments globally
  • New product emphasis: Innovations in mild surfactants, detergents, cold flow improvers, friction modifiers, biocides, and drilling mud additives
  • Strategic focus: Expanding geographical footprint and pursuing acquisitions to extend technology base and product portfolio
  • Notable metric: R&D spend $51.0M in 2025, down from $56.5M in 2024, supporting new technology development across segments
  • Unique fact: Only global producer of tetra ethyl lead for aviation gasoline marketed as AvGas

Risk Factors

  • Regulatory risk from U.S. EPA and FAA leaded AvGas phase-out by 2030 risks loss of AvGas income
  • Geopolitical risk from operations in Middle East, Asia-Pacific, Eastern Europe, Latin America with political instability and trade restrictions
  • Operational risk from ongoing multi-year ERP system implementation risking cost overruns, delays, business disruption
  • Competitive risk from larger competitors with better resources and emerging electric/hybrid vehicle technologies reducing gasoline/diesel demand
  • Key-person risk from dependence on senior management and technical staff affecting business continuity if lost

Management Discussion & Analysis

  • Revenue $1.778B, down 4% YoY; Performance Chemicals up $27.7M (4%), Fuel Specialties flat, Oilfield Services down $95.5M (19%)
  • Operating income $129.5M vs $177.9M, operating margin 7.3% vs 9.6%; Fuel Specialties best: $144.8M (+12%), Oilfield Services worst: $23.3M (-40%)
  • Gross margin down 1.7 points to 27.7%; Performance Chemicals margin 17.9% vs 22.7%, Fuel Specialties margin up to 36.0% vs 34.2%, Oilfield Services margin down to 29.9% vs 31.5%
  • Cash from operations after capex $63.9M; ended year with $292.5M cash and no debt; dividends up 10% to $1.71/share; repurchased 264K shares for $23.9M
  • 2026 outlook: focus on Performance Chemicals margin recovery, Oilfield Services income growth from Middle East and DRA expansion; Latin America activity not expected to resume

AI summary of the IOSP 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Q3 revenue $473.6M, up $31.7M or 7% YoY from $441.9M
  • Aggregate gross margin 27.3% vs 26.4% YoY, operating income $41.7M vs $5.9M
  • Best segment: Oilfield Services revenue $112.4M, up 13%; worst margin trend: Oilfield Services, 28.2% vs 30.0%
  • Cash $251.9M vs $292.5M at December 31; nine-month operating cash flow $42.2M vs $77.9M
  • Headwinds: supply constraints, weaker personal care demand, pricing pressure, higher raw-material costs and working-capital needs

Risk Factors

  • No material changes in risk factors since the 2025 Form 10-K
  • Carried-forward risks: potential material impact on results of operations
  • Carried-forward risks: potential material impact on financial condition

AI summary of the IOSP 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 3, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal quarter ended September 30, 2026 results announced
  • Press release contains the company’s reported financial results and operating commentary

Item 7.01: Regulation FD Disclosure

  • Semi-annual cash dividend declared at $0.94 per share
  • November 17, 2026 record date

Item EX-99.1: Item EX-99.1

  • Q3 revenue $473.6M, up 7%, with GAAP EPS $1.29 versus $0.52 year over year
  • Adjusted EBITDA $51.4M versus $44.2M, while adjusted EPS rose to $1.29 from $1.12
Filed Aug 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal quarter ended June 30, 2026 results announced by Innospec
  • Investor focus: quarterly earnings, revenue, margins and outlook in the accompanying press release

Item EX-99.1: Item EX-99.1

  • Q2 revenue $491.4M, up 12%, with operating income $39.7M, up 16%, signaling broad-based operating momentum
  • GAAP EPS $1.25 versus $0.94; adjusted EPS $1.27 versus $1.26, indicating special items drove much of reported EPS improvement
Filed Jun 4, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Board expanded from 7 to 8 directors, increasing governance capacity
  • Shelley Bausch appointed Class II director effective July 1, 2026, through 2027 annual meeting

AI summaries of IOSP 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for IOSP

Don't miss the next IOSP filing

  • Alerts as it files. A push when IOSP files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut IOSP, by share count.
  • Ask anything. An AI agent that reads every IOSP filing and answers with sources.

IOSP alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
PARRETTE LESLIE JBuyNov 10, 2026$79.69
Jones David B.AOct 1, 2026-
GRIFFIN HARDY LOUIS IIIAOct 1, 2026-
MCROBBIE IAN MALCOLMAOct 1, 2026-
BARNES CORBINAOct 1, 2026-
Williams PatrickAOct 1, 2026-
Cleminson IanAOct 1, 2026-
Poccia ClaudiaSellFeb 27, 2026$76.30

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$1.8B$1.8B
Gross Profit$591.1M$542.9M$492.4M
Operating Income-$177.9M$129.5M
Net Income$139.1M$35.6M$116.6M
Gross Margin-29.4%27.7%
Op. Margin-9.6%7.3%
Net Margin-1.9%6.6%
Balance Sheet
Total Assets$1.7B$1.7B$1.8B
Equity-$1.2B$1.3B
ROE-2.9%8.8%
Per Share
EPS$5.56$1.42$4.67
Cash Flow
Operating CF-$184.5M$138.3M

Source: XBRL data in INNOSPEC INC. (IOSP)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate IOSP share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
IOSP shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202630$1.33B
Q2 202629$1.11B
Q1 202631$951.5M
Q4 202528$999.6M
Q3 202529$1.01B
Q2 202530$1.06B
Q1 202529$808.9M
Q4 202425$805.3M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 231 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

IOSP filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
10-QNov 4, 2026Analysis
8-KNov 3, 2026Analysis-
4Oct 5, 2026--
4Oct 5, 2026--
4Oct 5, 2026--
4Oct 5, 2026--
4Oct 5, 2026--
4Oct 5, 2026--
10-QAug 5, 2026Analysis
8-KAug 5, 2026Analysis-
SC 13GJul 14, 2026-
8-KJun 4, 2026Analysis
8-KMay 13, 2026Analysis
8-KMay 8, 2026Analysis
10-QMay 8, 2026Analysis
SC 13GApr 30, 2026-
SC 13GApr 29, 2026-
4Mar 6, 2026--
4Mar 6, 2026--
4Mar 6, 2026--
4Mar 6, 2026--
4Mar 6, 2026--
4Mar 3, 2026--
4Mar 3, 2026--

Related Materials companies

All Materials →

IOSP SEC filings: frequently asked questions

Are IOSP insiders buying or selling?

In the last 90 days, INNOSPEC INC. (IOSP) officers, directors and 10% owners reported 1 open-market purchase worth $27,493 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold IOSP stock?

As of September 30, 2026, the largest INNOSPEC INC. (IOSP) holders among the 13F filers tracked by SignalX were BlackRock ($411.9 million), Vanguard Portfolio Management LLC ($179.2 million), Dimensional Fund Advisors ($130.8 million), Vanguard Capital Management LLC ($105.7 million), State Street Corp ($98.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was IOSP's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), INNOSPEC INC. (IOSP) reported revenue of $1.8 billion (down 3.7% from FY2024) and net income of $116.6 million. Diluted EPS was $4.67. The figures come from the XBRL data in the 10-K.

What are the main risks in IOSP's latest 10-K?

In the 10-K filed February 18, 2026, INNOSPEC INC. (IOSP) flagged: Regulatory risk from U.S. EPA and FAA leaded AvGas phase-out by 2030 risks loss of AvGas income. Geopolitical risk from operations in Middle East, Asia-Pacific, Eastern Europe, Latin America with political instability and trade restrictions. (AI summary of the Risk Factors section.)

What did IOSP report in its latest 8-K?

INNOSPEC INC. (IOSP) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Fiscal quarter ended September 30, 2026 results announced.

What are the latest IOSP SEC filings?

INNOSPEC INC. (IOSP) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 12, 2026.

What is IOSP's SEC CIK number?

INNOSPEC INC. (IOSP)'s SEC Central Index Key (CIK) is 1054905. EDGAR lists every IOSP filing under that number.

Ask anything about IOSP

The research agent reads IOSP's filings, financials, insider trades and 13F holders, then answers with sources.